SABCS: Handing Novartis a win, Lilly's Verzenio barely misses overall survival goal in first-line breast cancer
SABCS: Handing Novartis a win, Lilly's Verzenio barely misses overall survival goal in first-line breast cancer
aliu
Wed, 12/06/2023 - 09:40
